Acupuncture for overactive bladder: A randomized controlled trial

Obstetrics and Gynecology

Volumn 106, Issue 1, 2005, Pages 138-143

  Emmons, Sandra L ^a   Otto, Lesley ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACUPUNCTURE; ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION REFLEX; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY FREQUENCY;

EID: 21244449521     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000163258.57895.ec     Document Type: Article

References (24)

1. Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology 2002;60 suppl:7-12.
2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36.
3. Ouslander JG. Management of overactive bladder. N Engl J Med 2004;350:786-99.
4. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Definition of overactive bladder and epidemiology of urinary incontinence. Urology 1997;50 suppl:4-14.
5. Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V. Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003;43:535-8.
6. Hu TW, Wagner TH, Bentkover JD, LeBlanc K, Piancentini A, Stewart WF, et al. Estimated economic costs of overactive bladder in the United States. Urology 2003;61(6):1123-8.
7. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997;50 suppl:90-6.
8. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998;280:1995-2000.
9. Minni B, Capozza N, Creti G, De Gennaro M, Caione P, Bischko J. Bladder instability and enuresis treated by acupuncture and electro-therapeutics: early urodynamic observations. Acupunct Electrother Res 1990;15:19-25.
10. Chang PL. Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J Urol 1988;140:563-6.
11. Bergstrom K, Carlsson CP, Lindholm C, Widengren R. Improvement of urge- and mixed-type incontinence after acupuncture treatment among elderly women-a pilot study. J Auton Nerv Syst 2000;79:173-80.
12. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104:1374-9.
13. van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP. Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn 2003; 22:97-104.
14. Ellenberg SS. Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials. Oncology (Huntingt) 1989; 3:39-46.
15. Nygaard I, Holcomb R. Reproducibility of the seven-day voiding diary in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:15-7.
16. Brown JS, McNaughton KS, Wyman JF, Burgio KL, Harkaway R, Bergner D, et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 2003;61:802-9.
17. Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture-a review. Complement Ther Med 2003; 11:235-42.
18. White P, Lewith G, Hopwood V, Prescott P. The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 2003;106:401-9.
19. Haab F, Stewart L, Dwyer P. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur Urol 2004;45:420-9.
20. Millard R, Tuttle J, Moore K, Susset J, Clarke B, Dwyer P, et al. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol 1999;161:1551-5.
21. Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A. Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overacuve bladder. Urology 2001;57:414-21.
22. Zinner N, Gittelman M, Harris R, Susset J, Kanelos A, Auerbach S. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 2004;171: 2311-5.
23. Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc 2002;50:808-16.
24. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 2000;48:370-4.